Seeing Is Believing
with an average price target of $278.2. This is a potential upside of $276.63 (17619.75%) from yesterday's end of day stock price of $1.57.
Kala Pharmaceuticals's activity chart (see below) currently has 35 price targets and 52 ratings on display.
Analysts average stock forecasts to be materialized ratio is 11.24% with an average time for these price targets to be met of 40.22 days.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 06-Aug-2024. First documented stock forecast 13-Aug-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$15
$13.46 (874.03%)
$18
1 years 2 months 2 days ago
(06-Aug-2024)
3/7 (42.86%)
$8.86 (144.30%)
314
Buy
$22
$20.46 (1328.57%)
$47
1 years 10 months 25 days ago
(13-Nov-2023)
0/2 (0%)
$16.8 (323.08%)
Buy
3 years 1 months 24 days ago
(14-Aug-2022)
0/2 (0%)
$390 (108.33%)
Hold
3 years 6 months 9 days ago
(29-Mar-2022)
0/1 (0%)
$334 (54.22%)
Sell
3 years 6 months 9 days ago
(29-Mar-2022)
0/2 (0%)
$815 (87.17%)
What is KALA (Kala Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on KALA (Kala Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?
Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?
Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?